Objective:This study evaluated the secretions of zymogen and active forms of matrix metalloproteinase (MMP)-9 and MMP-2 and their specific inhibitors, TIMP-1 and TIMP-2 by fetal membranes stimulated with group B Streptoccocci (GBS).
Methods:We used an in vitro experimental model that allowed us to estimate the individual contribution of the amnion (AM) and the choriodecidua (CHD) to the microbial insult. Membranes were obtained after delivery by elective cesarean delivery from women at 37 to 40 weeks of gestation without evidence of either active labor of intrauterine infection. Membranes were mounted in Transwell devices (Costar, New York, NY), physically separating the upper and lower chambers; 1 × 106 CFU of GBS was added to either AM or CHD and the secretions and gelationlytic activity of MMP-2 and MMP-9 were measured in both compartments by enzyme-linked immunosorbent assay (ELISA) and zymography. TIMPs secretion was measured by ELISA. Both MMPs were immunolocalized in tissue sections.
Results:The simultaneous stimulation at both sides was followed by increases of proMMP-9 (85.0 ± 18.63 pg/mL) and proMMP-2 (4.10 ± 1.90 ng/mL) in the CHD (P < .05). When only one side of the membrane was stimulated, the secretion level of proMMP-2 increased 2.3-fold and that of proMMP-9 2.5-fold in the CHD. The active forms of the both enzymes did not change with any modality of stimulation. The secretion levels of both TIMPs remained without significant changes. CHD and AM were positive for immunoreactive MMP-2 and MMP-9.
Conclusion:We propose that infection of fetal membranes with GBS is followed by active secretion of MMP and the CHD is the principal source of these mediators of extracellular matrix degradation.
1. Malak TM, Ockleford CD, Bell SC, Dalgleish R, Bright N, Macvicar J. Confocal immunofluorescence localization of collagen types I, III, IV, V and VI and their ultrastructural organization in term human fetal membranes. Placenta1993;14:385-406.
2.
2. Malak TM, Mulholland G, Bell SC. Morphometric characteristics of the decidua, cytotrophoblast, and connective tissue of the prelabor ruptured fetal membranes. Ann N Y Acad Sci1994;734:430-433.
3.
3. Parry S, Strauss JF. Premature rupture of the fetal membranes. N Engl J Med1998;338:663-668.
4.
4. Vadillo-Oretga F, González-Avila G, Furth EE, et al. 92-kd type IV collagenase (matrix metalloproteinase-9) activity in human amniochorion increases with labor. Am J Pathol1995;146:148-156.
5.
5. Lei H, Vadillo-Ortega F, Paavola LG, Strauss JF. 92-Kda gelatinase (matrix metalloprteinase-9) is induced in rat amnion immediately prior to parturition. Biol Reprod1995;53:339-344.
6.
6. Bryant-Greenwood GD, Yamamoto SY. Control of peripartal collagenolysis in the human chorion-decidua. Am J Obstet Gynecol1995;172:63-70.
7.
7. Vadillo-Ortega F, Hernández A, González-Avila G, Bermejo L, Iwata K, Strauss JF. Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinase-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. Am J Obstet Gynecol1996;174:1371-1376.
8.
8. Halabourt JT, Uldberg N, Helmig R, Ohlsson K. The concentration of collagen and collagenolytic activity in the amnion and the chorion. Eur J Obstet Gynecol Reprod Biol1989;31:75-82.
9.
9. Fortunato SJ, Menon R, Lombardi SJ. MMP/TIMP imbalance in amniotic fluid during PROM: An indirect support for endogenous pathway to membrane rupture. J Perinat Med1999;27:362-368.
10.
10. Fortunato SJ, Menon, R, Lombardi SJ. Amniochorion gelatinase-gelatinase inhibitor imbalance in vitro. A possible infectious pathway to rupture. Obstet Gynecol2000;95:240-244.
11.
11. Romero R, Mazor M, Wu YK, Sirtori M, Oyarzun E, Mitchell MD, Hobbins JC. Infection in the pathogenesis of preterm labor. Sem Perinatol1988;12:262-279.
12.
12. Zaga V, Estrada-Gutierrez G, Beltran-Montoya J, Maida-Claros R, Lopez-Vancell R, Vadillo-Ortega F. Secretion of interleukin-1 beta and tumor neccrosis factor alpha by whole fetal membranes depends on initial interactions of amnion or chorion with lipopolysaccharides group B streptococci. Biol Reprod2004;71:1296-1302.
13.
13. Asrat T. Intra-amniotic infection in patients with preterm prelabor rupture of membranes. Pathophysiology, detection, and management. Clin Perinatal2001;28:735-751.
14.
14. Winram SB, Jonas M, Chi E, Rubens CE. Characterization of group B streptococcal invasion of human chorion and amnion epithelia cells in vitro. Infect Immun1998;66:4932-4941.
15.
15. Herbert MA, Beveridge CJE, Saunders NJ. Bacterial virulence factors in neonatal sepsis: Group B streptoccoccus. Curr Opin Infect Dis2004;17:225-229.
16.
16. Gravett MG, Haluska GJ, Cook MJ, Novy MJ. Fetal and maternal endocrine responses to experimental intrauterine infection in rhesus monkeys. Am J Obstet Gynecol1996;174:1725-1733.
17.
17. Dudley DJ, Edwin SS, Van Wagoner J, Augustine NH, Hill HR, Mitchell MD. Regulation of decidual cell chemokine production by group B streptococci and purified bacterial cell wall components. Am J Obstet Gynecol1997;177:666-672.
18.
18. Vadillo-Ortega F, Sadowski DW, Haluska GJ, et al. Identification of matrix metalloproteinase-9 in amniotic fluid and amniochorion in spontaneous labor and after experimental intrauterine infection or interleukin-1β infusion in pregnant rhesus monkeys. Am J Obstet Gynecol2002;186:128-138.
19.
19. Woessner JF. Quanitification of matrix metalloproteinases in tissue samples. Methods Enzymol1995;248:510-528.
20.
20. Hanemaaijer R, Sier CFM, Visser H, et al. MMP-9 activity in urine from patients with various tumors, as measured by a novel MMP activity assay using modified urokinase as a substrate. Ann N Y Acad Sci1999;878:141-149.
21.
21. Edwin SS, Romero R, Rathnasabapathy CM, Athayde N, Armant DR, Subramanian MG. Protein kinase C stimulates release of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by human decidual cells. J Matern Fetal Neonatal Med2002;12:231-236.
22.
22. Bryant-Greenwood GD. The extracellular matrix of the human fetal membranes: Structure and function. Placenta1998;19:1-11.
23.
23. Skinner SJM, Campos GA, Liggins GC. Collagen content of human amniotic membranes: Effect of gestation length and premature rupture. Obstet Gynecol1981;57:487-489.
24.
24. Vadillo-Ortega F, González-Avila G, Karchmer S, Meraz-Cruz N, Ayala-Ruiz A, Selman-Lama M. Collagen metabolism in premature rupture of amniotic membranes. Obstet Gynecol1990;75:84-88.
25.
25. Paavola LG, Emma EF, Delgado V, et al. Striking changes in the structure and organization of rat fetal membranes precede parturition. Biol Reprod1995;53:321-338.
26.
26. Newton ER. Preterm labor, preterm premature rupture of membranes and chorioamnionitis. Clin Perinatol2005;32:571-600.
27.
27. McGregor JA, Lawellin D, Franco-Buff A, Todd JK, Makowski L. Protease production by microorganisms associated with reproductive tract infection. Am J Obstet Gynecol1986;154:109-114.
29. Draper D, McGregor J, Hall J, et al. Elevated protease activities in human amnion and chorion correlate with preterm premature rupture of membranes. Am J Obstet Gynecol1995;173:1506-1512.
30.
30. Sato TA, Keelan JA, Mitchell MD. Critical paracrine interactions between TNFα and IL-10 regulate lipopolysaccharide-stimulated human choriodecidual cytokine and prostaglandin E2 production. J Immunol2003;170:158-166.
31.
31. Maymon E, Romero R, Pacora P, et al. Evidence of in vivo differential bioavailability of the active forms of matrix metalloproteinases 9 and 2 in parturition, spontaneous rupture of membranes, and intra-amniotic infection. Am J Obstet Gynecol2000;183:887-894.
32.
32. Peltier MR. Immunology of term and preterm labor. Reprod Biol Endocrinol2003;1:122-132.
33.
33. Fortunato SJ, Menon R, Lombardi SJ. Collagenolytic enzymes (gelatinases) and their inhibitors in human amniochorionic membrane. Am J Obstet Gynecol1997;177:731-741.
34.
34. Athayde N, Edwin SS, Romero R, et al. A role for matrix metalloproteinase-9 in spontaneous rupture of the fetal membranes. Am J Obstet Gynecol1998;179:1248-1253.
35.
35. Locksmith GJ, Clark P, Duff P, Schultz GS, Amniotic fluid matrix metallproteinase-9 levels in women with preterm labor and suspected intra-amniotic infection. Obstet Gynecol1999;94:1-6.
36.
36. Romero R, Chaiworapongsa T, Espinoza J, et al. Fetal plasma MMP-9 concentrations are elevated in preterm premature rupture of the membranes. Am J Obstet Gynecol2002;187:1125-1130.
37.
37. Maymon E, Romero R, Pacora P, et al. A role for the 72 kDa gelatinase (MMP-2) and its inhibitor (TIMP-2) in human parturition, premature rupture of membranes and intraamniotic infection. J Perinat Med2001;29:308-316.
38.
38. Kridel SJ, Chen E, Kotra LP, Howard EW, Mobashery S, Smith JW. Substrate hydrolysis by matrix metalloproteinase-9. J Biol Chem2001;276:20572-20578.
39.
39. Riley SC, Leask R, Chard T, Wathen NC, Calder AA, Howe DC. Secretion of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases into the intrauterine compartments during early pregnancy. Mol Hum Reprod1999;5:376-381.
40.
40. Hulboy DL, Rudolph LA, Matrisian LM. Matrix metalloproteinases as mediators of reproductive function. Mol Hum Reprod1997;3:27-45.
41.
41. Meraz-Cruz N, Molina DG, Vadillo-Ortega F. Cambios secuenciales de metaloproteinasas de matriz extracelular durante la gestación y el trabajo de parto en el corioalantoides de la rata. Rev Inv Clin2003;55:36-42.
42.
42. Vadillo-Ortega F, Estrada-Gutierrez G. Role of matrix metalloproteinases in preterm labour. BJOG2005;112:19-22.
